Table 2 The correlation between PSMD1 expression and clinicopathological parameters (n = 84).

From: Depletion of proteasome subunit PSMD1 induces cancer cell death via protein ubiquitination and DNA damage, irrespective of p53 status

Variables

TMEM165 Expression

p

 < 1.5 fold

≧1.5 fold

Gender

 Male

38

36

0.369

 Female

4

6

Age (year)

 â€‰< 52

16

20

0.254

 â€‰â‰¥â€‰52

26

22

AFP (ng/mL)

 â€‰< 100

32

18

0.001

 â€‰â‰¥â€‰100

9

24

AST (U/L)

 â€‰< 40

20

18

0.413

 â€‰â‰¥â€‰40

22

24

ALT (U/L)

 â€‰< 35

12

19

0.117

 â€‰â‰¥â€‰35

29

24

Child–Pugh classification

 A

34

34

0.515

 B

3

4

Tumor size (cm)

 â€‰< 7

32

23

0.044

 â€‰â‰¥â€‰7

10

18

Tumor stage

 I, II

18

14

0.113

 III, IV

10

17

Tumor number

 Single

29

28

0.5

 Multiple

8

9

Macroscopic vascular invasion

 No

38

36

0.488

 Yes

2

3

Microscopic vascular invasion

 No

17

17

0.549

 Yes

19

18

Edmondoson grade

 I, II

27

28

0.438

 III, IV

15

13

Cirrhosis

 No

24

22

0.355

 Yes

14

17

  1. Significance of PSMD1 overexpression in association with clinicopathological parameters was calculated using Chi-Square Test.
  2. Bold indicates p < 0.05. Statistically significant data in bold.